Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Treatment for Advanced B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab for Anti-cytokine Autoantibody-Associated Diseases
- Status
- COMPLETED
- Phase
- PHASE1
BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide Plus Rituximab (R) in Non Follicular NHL
- Status
- UNKNOWN
- Phase
- PHASE2
VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
- Status
- COMPLETED
- Phase
- PHASE2
Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
T&B Depletion Non Malignant
- Status
- UNKNOWN
- Phase
- PHASE2
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1